Plandaí Biotechnology, Inc.

PLPL

US72703D1000

Investment Holding Companies

Delayed OTC Markets Other stock markets 07:18:44 18/06/2024 pm IST			5-day change	1st Jan Change
0.0003 ^USD	-14.29%		0.00%	+50.00%

2023	Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.	CI
2023	Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc	CI

Plandai Biotechnology, Inc. Appoints Volker Boehm to its Scientific Board

February 22, 2012 at 07:00 pm IST

Plandai Biotechnology, Inc. announced that Dr. Volker Boehm has accepted a position on the company's scientific board. This appointment was enthusiastically supported and approved company-wide, particularly by Dr. Tom Matula, Chairman of the scientific Board.

Latest news about Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.	01/23/01	CI
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc	17/23/17	CI
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.	17/23/17	CI
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.	04/23/04	CI
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.	06/22/06	CI
Plandaí Biotechnology, Inc. Addresses Bioavailability and the Science of Phytofare from Previous Human Clinical Trial Results	10/18/10	CI
Plandai Biotechnology Announces Phytofare to Be Focus of Human Clinical Trial for Type II Diabetes in Mauritius	16/17/16	CI
Plandai Biotechnology Executes Exclusive Distribution Agreement with Cambridge Commodoties for UK and All of Europe	08/17/08	CI
Plandaí Biotechnology, Inc. Receives 1.2 Million Origine 8 Capsule Order from Coyne Healthcare	02/17/02	CI
Plandai Biotechnology, Inc Appoints Ezra Jones as Vice President of Sales and Marketing	28/17/28	CI
NutriBullets SuperFood Boost Featuring Plandai Biotechnology's Phytofare Expected to Hit Retailers in May 2017	24/17/24	CI
Plandaí Biotechnology, Inc. Names Callum Cottrell-Duffield as President and Chief Operating Officer	27/17/27	CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.	27/17/27	CI
Plandai Biotechnology Enters Pact in Principal with North West University for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes	31/16/31	CI
Plandaí Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt	30/16/30	CI
Plandai Biotechnology, Inc. to Include Phytofare® Catechin-Propheroid® Formulation in Grain-Based Pellets	24/16/24	CI
Plandai Biotechnology, Inc. Announces VitaminExpress	10/16/10	CI
Plandai Biotechnology, Inc. Announces Sales Results for the Month April 2016	29/16/29	CI
Plandai Biotechnology Signs Distribution Agreement with AIDP	04/16/04	CI
Plandaí Biotechnology, Inc. Announces Management Changes	03/16/03	CI
Plandai Biotechnology, Inc. Announces License Agreement with Coyne Healthcare	02/16/02	CI
Plandai Biotechnology Executes Distribution Agreement with Bal Pharma Ltd Covering India	27/15/27	CI
Ultimate Sports Nutrition Develops New Products Using Phytofare	26/15/26	CI
Plandaí Biotechnology, Inc. Announces Expansion of Agreement with USN to Now Include the European Union	10/15/10	CI
Plandai Biotechnology to Deliver Green Tea Extract to USN	16/15/16	CI

Chart Plandaí Biotechnology, Inc.

Duration

Period

More charts

Company Profile

Plandai Biotechnology, Inc. is a biotech company, which is focused on the production of botanical extracts for the nutraceutical and pharmaceutical industries. The Company grows the green tea used in its products on a 3,000-hectare estate in the Mpumalanga region of South Africa. Its marketed product, Phytofare Catechin Complex, is a green-tea-derived extract that has multiple potential wellness applications. It caters to airline flights and operated coffee shops, lounges and gift shops at airports, and other facilities located in Florida, Alabama, and Georgia. Its airline catering services include the preparation of meals in kitchens located at, or adjacent to, airports and the distribution of meals and beverages for service on commercial airline flights. The Company also provides certain ancillary services, including the preparation of beverage service carts, the unloading and cleaning of plates, utensils and other accessories arriving on incoming aircraft, and other.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
PLANDAÍ BIOTECHNOLOGY, INC.	+50.00%	3.11M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+87.49%	6.14B
APPLE ISPORTS GROUP, INC.	+98.02%	1.23B
CHURCHILL CAPITAL CORP VII	+2.57%	986M
PERELLA WEINBERG PARTNERS	+17.66%	763M
ARES ACQUISITION CORPORATION II	+2.11%	666M
E7 GROUP	+2.33%	621M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+8.61%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies

Plandaí Biotechnology, Inc.

Equities

PLPL

US72703D1000

Investment Holding Companies

Plandai Biotechnology, Inc. Appoints Volker Boehm to its Scientific Board

Latest news about Plandaí Biotechnology, Inc.

Chart Plandaí Biotechnology, Inc.

Company Profile

Sector Shell Companies